Wednesday, October 26, 2016

Carmustine




In some countries, this medicine may only be approved for veterinary use.


In the US, Carmustine (carmustine systemic) is a member of the drug class alkylating agents and is used to treat Brain Tumor, Glioblastoma Multiforme, Hodgkin's Lymphoma, Malignant Glioma, Multiple Myeloma and Non-Hodgkin's Lymphoma.

US matches:

  • Carmustine

  • Carmustine Implant Wafer

  • Carmustine Implantation

  • Carmustine Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01AD01

CAS registry number (Chemical Abstracts Service)

0000154-93-8

Chemical Formula

C5-H9-Cl2-N3-O2

Molecular Weight

214

Therapeutic Category

Antineoplastic agent, alkylating agent

Chemical Name

Urea, N,N'-bis(2-chloroethyl)-N-nitroso-

Foreign Names

  • Carmustinum (Latin)
  • Carmustin (German)
  • Carmustine (French)
  • Carmustina (Spanish)

Generic Names

  • Carmustina (OS: DCIT)
  • Carmustine (OS: BAN, USAN, DCF)
  • BCNU (IS)
  • NSC 409962 (IS)
  • SK 27702 (IS)
  • Carmustin (PH: Ph. Eur. 6)
  • Carmustine (PH: BP 2010, Ph. Eur. 6)
  • Carmustinum (PH: Ph. Eur. 6)

Brand Names

  • BiCNU
    Bristol-Myers Squibb, United Arab Emirates; Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Bosnia & Herzegowina; Bristol-Myers Squibb, Bahrain; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Cote D'ivoire; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Algeria; Bristol-Myers Squibb, Egypt; Bristol-Myers Squibb, France; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Iraq; Bristol-Myers Squibb, Iran; Bristol-Myers Squibb, Jordan; Bristol-Myers Squibb, Kuwait; Bristol-Myers Squibb, Lebanon; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Oman; Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Philippines; Bristol-Myers Squibb, Qatar; Bristol-Myers Squibb, Saudi Arabia; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, Syria; Bristol-Myers Squibb, Tunisia; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Yemen; Bristol-Myers Squibb, South Africa; IFET, Greece


  • BiCNU (veterinary use)
    Bristol-Myers Squibb, United Kingdom


  • Carmubris
    Bristol-Myers Squibb, Austria; IFET, Greece


  • Gliadel Wafer
    Medison, Israel; MGI, United States


  • Gliadel
    Archimedes, United Kingdom; Dompé, Italy; Eisai, United States; Generics, Greece; Orphan, Australia; Pensa, Spain; Pharmaplan, South Africa; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal


  • Nitrumon
    Almirall, Luxembourg

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment